DOPAMINE TRANSPORTER/MU OPIATE RECEPTOR--CELLULAR AND SUBCELLULAR LOCALIZATIONS
DOPAMINE TRANSPORTER/MU OPIATE RECEPTOR--CELLULAR AND SUBCELLULAR LOCALIZATIONS
批准号:
6103872
负责人:
G R UHL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
多巴胺转运体(DAT)和MU阿片剂
受体(MOR)已被确定为主要的大脑受体
与奖励和愉悦特性相关的网站
可卡因和吗啡。蜂窝和亚蜂窝定位数据是
重要的是有助于阐明这些的功能属性
重要的大脑分子。在本财年,有关分发
大鼠脑内的DAT和MOR蛋白已基本完成。
对转运蛋白的超微结构研究表明,大多数
DAT和MOR在细胞内和细胞内呈阳性反应
质膜定位不容易与
传统的突触特化。这些研究实质上
添加有关这些组件的详细蜂窝定位的信息
可卡因和吗啡奖励的重要地点。他们强调
突触外移除多巴胺的可能性提供了一个
DAT的主要功能。
英文摘要
The dopamine transporter (DAT) and mu opiate
receptor (MOR) have been identified as the principal brain receptor
sites correlated with the rewarding and euphoric properties of
cocaine and morphine. Cellular and subcellular localization data are
important to help to elucidate the functional properties of these
important brain molecules. In this FY, reports of the distribution of
the DAT and MOR proteins in rat brains were largely completed.
Ultrastructural studies of the transporter revealed that most of the
DAT and MOR immunoreactivity was found in intracellular and
plasma membrane localizations not readily associated with
conventional synaptic specializations. These studies substantially
add to information on the detailed cellular localizations of these
important sites for cocaine and morphine reward. They underscore
the likelihood that extrasynaptic removal of dopamine provides a
principal function of DAT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENETIC APPROACHES TO CHARACTERIZING DRUG RESPONSES AND VULNERABILITIES
-
批准号:2571616
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE TRANSPORTER-- CELLULAR AND SUBCELLULAR LOCALIZATIONS
-
批准号:5201668
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
GENES RELATED TO DRUG ABUSE--REGULATION OF OPIOID PEPTIDE GENES
-
批准号:3853715
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINERGIC LESIONS AND SUBJECTIVE EFFECTS OF METHYLPHENIDATE
-
批准号:3853679
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
RECEPTOR CDNA EXPRESSION CLONING USING LIGAND AUTORADIOGRAPHIC SCREENING
-
批准号:3853713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE TRANSPORTER--STRUCTURE/FUNCTION STUDIES OF TRANSPORTER AND LIGANDS
-
批准号:6161689
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE TRANSPORTER/MU OPIATE RECEPTOR--CELLULAR AND SUBCELLULAR LOCALIZATIONS
-
批准号:6161706
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
HUMAN DOPAMINERGIC GENES AND SUBSTANCE ABUSE VULNERABILITY
-
批准号:3775068
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
PSYCHOSTIMULANT EFFECTS IN HUMANS WITH DOPAMINE LESIONS
-
批准号:3775007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE TRANSPORTER--STRUCTURE/FUNCTION STUDIES OF TRANSPORTER AND LIGANDS
-
批准号:2571595
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
MOUSE SYNAPTIC VESICULAR MONAMINE TRANSPORTER--CDNA AND GENOMIC STRUCTURE
-
批准号:2571614
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE TRANSPORTER--HUMAN & MOUSE GENES, DOPAMINERGIC DISORDERS & KNOCKOUT MICE
-
批准号:6161704
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE D2 RECEPTOR GENE MARKERS AND SUBSTANCE ABUSE VULNERABILITY
-
批准号:3838650
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
GENES REGULATED BY ABUSED DRUGS IN BRAIN--GENES INVOLVED IN NEURAL SIGNALING
-
批准号:2571610
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
GENETIC APPROACHES TO CHARACTERIZING DRUG RESPONSES AND VULNERABILITIES
-
批准号:6161736
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
HIV IN INJECTION DRUG USERS
-
批准号:2449762
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
DOPAMINE TRANSPORTER I--REGULATION BY PHOSPHORYLATION
-
批准号:2571612
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
BIOCHEMICAL AND BEHAVIORAL CONSEQUENCES IN TRANSGENIC MICE
-
批准号:2449761
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
IN VIVO ASSESSMENTS IN DRUG USERS
-
批准号:2449763
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
MU OPIATE RECEPTOR--CELLULAR AND SUBCELLULAR LOCALIZATIONS
-
批准号:2571615
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:G R UHL
-
依托单位:
海外基金